BioCentury
ARTICLE | Company News

Helix BioMedix, DermaVentures LLC deal

April 30, 2007 7:00 AM UTC

HXBM granted DermaVentures non-exclusive rights to develop and market an undisclosed peptide technology in North and Central America. DermaVentures will use the technology in its P.A.C. Perfect OTC ac...